Loading
Zurich radiation oncologist and ESTRO Past-President, a leading voice on stereotactic radiotherapy for oligometastases.
Matthias Guckenberger is Past-President of ESTRO and serves on its board; he is a radiation oncologist at University Hospital Zurich. His research focuses on stereotactic body radiotherapy, the characterisation and treatment of oligometastatic disease, and radiotherapy for lung cancer. He has led European consensus work defining oligometastatic disease and its treatment.
Shares European Society for Radiotherapy and Oncology and the tags leadership, clinician-scientist, radiotherapy.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.
Shares Non-small-cell lung cancer and the tags leadership, clinician-scientist, lung cancer.